FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to formula (I) compounds and their pharmaceutically acceptable salts. Invention compounds can be applied as PDE10A-inhibiting therapeutically active substances. In formula (I) R1 represents phenyl or thienyl, where phenyl and thienyl are optionally substituted with 1 substituent, selected from the group, consisting of hydroxyl, halogen atom, lower alkoxy, lower halogenalkoxy, -OC(O)-lower alkyl, -OCH2C(O)-lower alkoxy and phenyl; R2 represents 5- or 6-membered monocyclic heteroaryl, which has from 1 to 3 heteroatoms, independently selected from N and O, where heteroaryl is optionally substituted with from 1 to 3 substituents, independently selected from the group, consisting of , halogen atom, nitro, lower alkyl, lower alkenyl, lower alkoxy, lower alkoxy -C(O)-, lower halogenalkyl, lower alkoxy - lower alkyl, C3-C6cycloalkyl, phenyl, 5-membered monocyclic heteroaryl, which has 2 heteroatoms, independently selected from N and O, and amino, substituted with 6-membered heteroaryl, which has 2 heteroatoms, selected from N, where two substituents R2 together with heteroaryl, which they are bound to, can form 9-membered bicyclic ring; R8 represents hydrogen atom. Values of other radicals are given in invention formula. Invention also relates to formula (I') compounds, structural formula and values of radicals are given in invention formula. Invention also discloses pharmaceutical compositions and application of compounds for obtaining medication.
EFFECT: obtaining novel formula (I) compounds, possessing properties of PDE10A inhibitor.
15 cl, 176 ex
Title | Year | Author | Number |
---|---|---|---|
IMIDAZOPYRIDINE OR IMIDAZOPYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE 10A INHIBITORS | 2010 |
|
RU2502737C2 |
PALLADIUM-CATALYSED COUPLING OF PYRAZOLE AMIDES | 2014 |
|
RU2663834C2 |
CHEMICAL COMPOUNDS | 2007 |
|
RU2469034C2 |
DERIVATIVES OF BENZIMIDAZOL INHIBITING FACTOR Xa | 2004 |
|
RU2346944C2 |
BENZAZEPINE DICARBOXAMIDE COMPOUND | 2016 |
|
RU2712248C2 |
HETEROCYCLIC INHIBITORS OF Hh-SYGNAL CASCADE, BASED ON THEM MEDICINAL COMPOSITIONS AND METHOD OF TREATING DISEASES INDUCED BY ABBARANT ACTIVITY OF Hh-SIGNAL SYSTEM | 2007 |
|
RU2364597C1 |
N-PYRIDIN-3-YL OR N-PYRAZIN-2-YL CARBOXAMIDES AS AGENTS INCREASING LEVEL OF HDLP CHOLESTEROL | 2011 |
|
RU2540069C2 |
NOVEL CONDENSED PYRIDINE DERIVATIVES USED AS C-MET TYROSINE KINASE INHIBITORS | 2013 |
|
RU2619130C2 |
NITROGEN-CONTAINING HETEROARYL DERIVATIVES | 2011 |
|
RU2559895C2 |
HETEROARYL PIPERAZINE DERIVATIVE, METHOD FOR ITS PREPARATION AND APPLICATION IN MEDICINE | 2018 |
|
RU2745431C1 |
Authors
Dates
2015-09-10—Published
2011-03-23—Filed